Jiajun Xu

2.2k total citations
87 papers, 1.6k citations indexed

About

Jiajun Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jiajun Xu has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Cancer Research and 12 papers in Surgery. Recurrent topics in Jiajun Xu's work include Nanoplatforms for cancer theranostics (10 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers) and MicroRNA in disease regulation (6 papers). Jiajun Xu is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers) and MicroRNA in disease regulation (6 papers). Jiajun Xu collaborates with scholars based in China, United States and Singapore. Jiajun Xu's co-authors include Weigang Xu, Shoujun Zhu, Jibo Han, Tianyang Han, Xuejun Sun, Hengyi Tao, Feng Gao, Zhimin Kang, Runping Li and Guoyang Huang and has published in prestigious journals such as Advanced Materials, Nature Communications and Nano Letters.

In The Last Decade

Jiajun Xu

80 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiajun Xu China 24 730 268 212 212 161 87 1.6k
Jacqueline L. Whatmore United Kingdom 26 860 1.2× 243 0.9× 138 0.7× 170 0.8× 159 1.0× 58 2.2k
Xiaoxia Yang China 24 606 0.8× 311 1.2× 222 1.0× 145 0.7× 103 0.6× 55 1.8k
Chuanyu Li China 16 839 1.1× 236 0.9× 145 0.7× 366 1.7× 205 1.3× 55 1.9k
Tian Xie China 25 874 1.2× 209 0.8× 157 0.7× 404 1.9× 68 0.4× 63 1.8k
Yuyu Yao China 28 988 1.4× 195 0.7× 238 1.1× 329 1.6× 102 0.6× 104 2.3k
Sergiu Șușman Romania 17 801 1.1× 161 0.6× 200 0.9× 407 1.9× 86 0.5× 58 1.8k
Alessandro Corbelli Italy 25 1.2k 1.6× 170 0.6× 90 0.4× 421 2.0× 109 0.7× 50 2.1k
Shengjie Xu China 18 631 0.9× 104 0.4× 119 0.6× 263 1.2× 206 1.3× 33 1.4k
Wenhong Xu China 23 970 1.3× 218 0.8× 132 0.6× 154 0.7× 293 1.8× 54 1.9k
Zhenyu Yin China 22 1.2k 1.6× 163 0.6× 170 0.8× 540 2.5× 125 0.8× 71 2.1k

Countries citing papers authored by Jiajun Xu

Since Specialization
Citations

This map shows the geographic impact of Jiajun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajun Xu more than expected).

Fields of papers citing papers by Jiajun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajun Xu. The network helps show where Jiajun Xu may publish in the future.

Co-authorship network of co-authors of Jiajun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajun Xu. A scholar is included among the top collaborators of Jiajun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajun Xu. Jiajun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wu, Wenbin, Jianjin Wu, Jiajun Xu, et al.. (2024). Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence. Nature Communications. 15(1). 1429–1429. 43 indexed citations
4.
Yi, Cheng, Jiafeng Zou, Muye He, et al.. (2024). Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy. Journal of Controlled Release. 367. 167–183. 13 indexed citations
5.
Fu, Jiang‐Tao, Ping Zhang, Guo‐Dong Lu, et al.. (2024). A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment. Acta Pharmaceutica Sinica B. 14(5). 2228–2246. 17 indexed citations
6.
Zhang, Feiran, Jiajun Xu, Chengbin Zhang, et al.. (2023). Three-Dimensional Histological Electrophoresis for High-Throughput Cancer Margin Detection in Multiple Types of Tumor Specimens. Nano Letters. 23(16). 7607–7614. 4 indexed citations
7.
Xu, Jiajun, et al.. (2022). Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease. Gene Therapy. 30(1-2). 31–40.
8.
Qu, Zhi, et al.. (2021). Is amyloid fibrillation related to 3D domain swapping for the C-terminal domain of SARS-CoV main protease?. International Journal of Biological Macromolecules. 197. 68–76. 1 indexed citations
9.
Xu, Jiajun, Muye He, Xinyu Hou, et al.. (2019). Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology. Molecular Pharmaceutics. 17(1). 301–315. 5 indexed citations
10.
Yuan, Bao, Hongyan Chen, Ming-Qiang Xu, et al.. (2018). Effects of MiR-375-BMPR2 as a Key Factor Downstream of BMP15/GDF9 on the Smad1/5/8 and Smad2/3 Signaling Pathways. Cellular Physiology and Biochemistry. 46(1). 213–225. 39 indexed citations
11.
Xu, Jiajun, et al.. (2017). Intravenous injection of Xuebijing attenuates acute kidney injury in rats with paraquat intoxication. World Journal of Emergency Medicine. 8(1). 61–61. 16 indexed citations
12.
Zhang, Kun, Zhongxin Jiang, Xuhua Yu, et al.. (2017). Endothelia-Targeting Protection by Escin in Decompression Sickness Rats. Scientific Reports. 7(1). 41288–41288. 16 indexed citations
13.
Yu, Xuhua, et al.. (2017). Bubble-Induced Endothelial Microparticles Promote Endothelial Dysfunction. PLoS ONE. 12(1). e0168881–e0168881. 18 indexed citations
14.
Wang, Liping, Ying Yao, Rong He, et al.. (2016). Methane ameliorates spinal cord ischemia-reperfusion injury in rats: Antioxidant, anti-inflammatory and anti-apoptotic activity mediated by Nrf2 activation. Free Radical Biology and Medicine. 103. 69–86. 89 indexed citations
15.
Xu, Jiajun, Guoyang Huang, Kun Zhang, et al.. (2014). Nrf2 Activation in Astrocytes Contributes to Spinal Cord Ischemic Tolerance Induced by Hyperbaric Oxygen Preconditioning. Journal of Neurotrauma. 31(15). 1343–1353. 48 indexed citations
16.
Huang, Guoyang, Jiajun Xu, Shifeng Wang, et al.. (2014). Hyperbaric Oxygen Preconditioning Induces Tolerance against Oxidative Injury and Oxygen-Glucose Deprivation by Up-Regulating Heat Shock Protein 32 in Rat Spinal Neurons. PLoS ONE. 9(1). e85967–e85967. 23 indexed citations
17.
Sun, Jingchuan, et al.. (2014). Hydrogen-Rich Saline Promotes Survival of Retinal Ganglion Cells in a Rat Model of Optic Nerve Crush. PLoS ONE. 9(6). e99299–e99299. 25 indexed citations
18.
Cai, Jiping, Jiajun Xu, Jianmei Cai, et al.. (2011). Protective Effects of Hydrogen Saline on Diabetic Retinopathy in a Streptozotocin-Induced Diabetic Rat Model. Journal of Ocular Pharmacology and Therapeutics. 28(1). 76–82. 15 indexed citations
19.
Lin, Haiyan, Nimmi Baby, Jia Lu, et al.. (2011). Expression of sphingosine kinase 1 in amoeboid microglial cells in the corpus callosum of postnatal rats. Journal of Neuroinflammation. 8(1). 13–13. 14 indexed citations
20.
Xu, Jiajun, Runping Li, Tonghai Dou, et al.. (2009). Normoxic induction of cerebral HIF-1α by acetazolamide in rats: Role of acidosis. Neuroscience Letters. 451(3). 274–278. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026